BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

29 related articles for article (PubMed ID: 10714502)

  • 1. Perspectives on biologically active camptothecin derivatives.
    Liu YQ; Li WQ; Morris-Natschke SL; Qian K; Yang L; Zhu GX; Wu XB; Chen AL; Zhang SY; Nan X; Lee KH
    Med Res Rev; 2015 Jul; 35(4):753-89. PubMed ID: 25808858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel C-ring analogues of 20(S)-camptothecin-part-2: synthesis and in vitro cytotoxicity of 5-C-substituted 20(S)-camptothecin analogues.
    Subrahmanyam D; Venkateswarlu A; Venkateswara Rao K; Sastry TV; Vandana G; Kumar SA
    Bioorg Med Chem Lett; 1999 Jun; 9(12):1633-8. PubMed ID: 10397491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel hexacyclic camptothecin derivatives. Part 1: synthesis and cytotoxicity of camptothecins with an A-ring fused 1,3-oxazine ring.
    Wang S; Li Y; Liu Y; Lu A; You Q
    Bioorg Med Chem Lett; 2008 Jul; 18(14):4095-7. PubMed ID: 18554906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and antitumor activity of novel 10-substituted camptothecin analogues.
    Li Q; Zu Y; Shi R; Yao L; Fu Y; Yang Z; Li L
    Bioorg Med Chem; 2006 Nov; 14(21):7175-82. PubMed ID: 16870453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Semi-synthesis and biological activity of gamma-lactones analogs of camptothecin.
    Li M; Tang W; Zeng F; Lou L; You T
    Bioorg Med Chem Lett; 2008 Dec; 18(24):6441-3. PubMed ID: 18986807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and in vitro cytotoxicity of C(20)(RS)-camptothecin analogues modified at both B (or A) and E ring.
    Jew SS; Kim MG; Kim HJ; Rho EY; Park HG; Kim JK; Han HJ; Lee H
    Bioorg Med Chem Lett; 1998 Jul; 8(14):1797-800. PubMed ID: 9873436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel C-ring analogues of 20(S)-camptothecin. Part 3: synthesis and their in vitro cytotoxicity of A-, B- and C-ring analogues.
    Subrahmanyam D; Sarma VM; Venkateswarlu A; Sastry TV; Srinivas AS; Krishna CV; Deevi DS; Kumar SA; Babu MJ; Damodaran NK
    Bioorg Med Chem Lett; 2000 Feb; 10(4):369-71. PubMed ID: 10714502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transport mechanism-based drug molecular design: novel camptothecin analogues to circumvent ABCG2-associated drug resistance of human tumor cells.
    Ishikawa T; Ikegami Y; Sano K; Nakagawa H; Sawada S
    Curr Pharm Des; 2006; 12(3):313-25. PubMed ID: 16454746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review camptothecin: current perspectives.
    Li QY; Zu YG; Shi RZ; Yao LP
    Curr Med Chem; 2006; 13(17):2021-39. PubMed ID: 16842195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and pharmacology of new camptothecin drugs.
    Driver RW; Yang LX
    Mini Rev Med Chem; 2005 May; 5(5):425-39. PubMed ID: 15892685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Homocamptothecins--novel promising anticancer drugs as inhibitors of topoisomerase I].
    Yang S; Zhang WN
    Yao Xue Xue Bao; 2004 May; 39(5):396-400. PubMed ID: 15338888
    [No Abstract]   [Full Text] [Related]  

  • 12. The cascade radical annulation approach to new analogues of camptothecins. Combinatorial synthesis of silatecans and homosilatecans.
    Curran DP; Josien H; Bom D; Gabarda AE; Du W
    Ann N Y Acad Sci; 2000; 922():112-21. PubMed ID: 11193887
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.